Capsaicin: all 105 studies that test it

Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Marsili Syndrome as a Gateway to Novel Analgesic TargetsNot yet recruitingNCT07755930Not applicable
• Pain Beliefs and Intracortical Excitability During Experimental PainNot yet recruitingNCT07688525Not applicable
• Chemotherapy Induced Peripheral Neuropathy by Taxanes and Capsaicin 8%.RecruitingNCT07602387Not applicable
• Efficacy of a Topical Palmitated Formulation of Capsaicin (Capsadyn®) In the Treatment of Diabetic Neuropathic Foot PainRecruitingNCT07260656Early Phase 1
• Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot StudyRecruitingNCT06744816Early Phase 1
• Acute Effect of Capsimax on Resistance Exercise Performance, Muscle Oxygenation, Nitric Oxide Release, Resting Energy Expenditure and Reaction TimeNot yet recruitingNCT06612658Not applicable
• Capsaicin in Digital Osteoarthritis Versus ControlRecruitingNCT06444919Phase 4
• Transient Receptor Potential ChannelsEnrolling by invitationNCT06444594Early Phase 1
• Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.RecruitingNCT06023706Phase 3
• Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in ChildrenRecruitingNCT05997979Phase 3
• Effects of 6-month of Treatment With TRPV1 and TRPA1 Agonists in Older Patients With ODNot yet recruitingNCT05958173Not applicable
• Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral NeuropathyRecruitingNCT05840562Phase 3
• Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)RecruitingNCT05560516Not applicable
• Capsaicin for Post-stroke DysphagiaRecruitingNCT04470752Phase 2
• Pain Biomarker StudyEnrolling by invitationNCT03511846Phase 1
• The Influence of Capsaicin Gel During Exercise Within the HeatCompletedNCT05298202Phase 4Results posted
• The Prevalence of Local Immunoglobulin E (IgE) Elevation and Its Effect on Intranasal Capsaicin Therapy in the Non-allergic Rhinitis PopulationCompletedNCT05093478Phase 3Results posted
• Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After SurgeryCompletedNCT04967664Phase 3Results posted
• Evaluation in the Treatment of Neuropathic Pain Post Breast SurgeryCompletedNCT03794388Phase 3Results posted
• Topical Capsaicin for Cyclical VomitingCompletedNCT03223350Phase 2Results posted
• Normal Breathing and Swallowing in Healthy VolunteersCompletedNCT03122145Phase 1/2Results posted
• Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy VolunteersCompletedNCT03074162Phase 1Results posted
• Biomarker Study in Participants With MigraineCompletedNCT02766517Early Phase 1Results posted
• Capsaicin + Diclofenac Gel in Acute Back Pain or Neck PainCompletedNCT02700815Phase 3Results posted
• Intranasal Capsaicin Treatment for Non-Allergic Irritant RhinitisCompletedNCT02493257Phase 2Results posted
• Capsaicin 8% Patch for Spinal Cord Injury Neuropathic PainCompletedNCT02441660Not applicableResults posted
• Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac IschemiaCompletedNCT02346916Not applicableResults posted
• Chest Pain Perception and Capsaicin SensitivityCompletedNCT02346903Not applicableResults posted
• Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic RhinitisCompletedNCT02288156Phase 4Results posted
• Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's DiseaseCompletedNCT02183519Phase 1/2Results posted
• Respiratory Kinematics During Voluntary and Reflex Cough in Healthy AdultsCompletedNCT01854268Phase 1/2Results posted
• A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN)CompletedNCT01533428Phase 3Results posted
• The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site PainCompletedNCT01260454Phase 2Results posted
• Efficacy of Topical Capsaicin Cream for Stable AnginaTerminatedNCT01231750Phase 3Results posted
• Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy SubjectsCompletedNCT00655811Phase 4Results posted
• Study of NGX-4010 for the Treatment of Painful HIV-Associated NeuropathyCompletedNCT00321672Phase 3Results posted
• Peripheral KV7 Activation for Pain ReliefCompletedNCT06971250Early Phase 1
• A Study to Evaluate Laser Speckle Contrast Imaging to Assess Changes in Chemical Agent-Induced Skin Blood Flow in Healthy Participants (MK-0000-420)CompletedNCT06809569Phase 1
• Thermosensitivity of a Topical Palmitated Formulation of CapsaicinCompletedNCT05649228Early Phase 1
• Capsaicin for Cerebral Perfusion AugmentationCompletedNCT05543837Phase 2
• Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.CompletedNCT05029297Phase 3
• Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)CompletedNCT04918069Phase 2
• Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.CompletedNCT04704453Phase 2
• Capsaicin for Cerebral Perfusion Augmentation.CompletedNCT04545892Phase 1
• Capsaicin for the Treatment of Cannabinoid Hyperemesis SyndromeCompletedNCT04283292Phase 4
• The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic NeuropathyCompletedNCT04238208Phase 4
• Quantitative Ultrasound Response of CapsaicinCompletedNCT03944889Early Phase 1
• Sickle Cell Pain: Intervention With Capsaicin ExposureCompletedNCT03899246Phase 1
• Capsaicin Energy Expenditure and Glucose MetabolismStatus unknownNCT03859583Not applicable
• The Effect of Injection Site Cooling on Pain Experienced After the Administration of CNTX-4975-05 Into the KneeCompletedNCT03472677Phase 1
• Localized Neuropathic Pain: Topical Treatment Versus Systemic TreatmentTerminatedNCT03348735Phase 4
• Clinical Trial Assessing the Efficacy of Capsaicin Patch (Qutenza®) in Cancer Patients With Neuropathic PainCompletedNCT03317613Phase 2
• Capsaicin Patches In Knee Osteoarthritis In Obese PatientsTerminatedNCT03153813Phase 3
• Ibuprofen Gel or Capsaicin Cream for my Painful Knee Osteoarthritis?CompletedNCT03146689Not applicable
• Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-mentholStatus unknownNCT03132142Not applicable
• Effect of Muscular Exercise on Cough ReflexCompletedNCT02882555Not applicable
• A Study of the Effects of Topical Capsaicin in the Treatment of Provoked VestibulodyniaTerminatedNCT02854670Phase 2/3
• Capsaicin Effect on Cytokines Profile in DyslipidemiaStatus unknownNCT02823912Phase 2/3
• Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic ItchCompletedNCT02769910Phase 1/2
• Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710162Early Phase 1
• Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT02710110Early Phase 1
• Pain Thresholds Under High-dose Topical CapsaicinCompletedNCT02570841Phase 4
• Study to Evaluate the Safety and Tolerability of CNTX-4975 in Subjects With Painful Intermetatarsal Neuroma (Morton's Neuroma)CompletedNCT02550756Phase 1
• Capsaicinoid Ingestion, Human Metabolism and Exercise (Phase 2)WithdrawnNCT02138630Not applicable
• Capsaicin on Salty Gustatory CorticesCompletedNCT01974037Phase 4
• Comparison of NSAID Patch Given in Monotherapy and NSAID Patch in Combination With Transcutaneous Electric Nerve Stimulation, Heating Pad, or Topical Capsaicin in the Treatment of Patients With Myofascial Pain Syndrome of the Upper Trapezius: A Pilot StudyCompletedNCT01884116Not applicable
• The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin CreamCompletedNCT01883102Phase 1
• Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and ControlsCompletedNCT01862523Phase 4
• A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of TreatmentCompletedNCT01713426Phase 4
• Qutenza for Critical Ischaemia in End Stage Renal FailureStatus unknownNCT01704339Phase 4
• Capsaicin Patch 8 % for the Treatment of Persistent Pain After Inguinal HerniotomyTerminatedNCT01699854Phase 3
• The Effect of Capsaicin and Cinnamaldehyde on Intestinal PermeabilityCompletedNCT01667523Not applicable
• A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic PatientsCompletedNCT01478607Phase 3
• Qutenza®-Remodulin® in Pulmonary Arterial Hypertension PatientsCompletedNCT01393795Phase 2
• Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve DamageCompletedNCT01252160Phase 4
• Study of NGX-1998 for the Treatment of Postherpetic NeuralgiaCompletedNCT01228838Phase 2
• Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin.CompletedNCT01223820Phase 4
• Efficacy of Topical Capsaicin on Chronic Neck PainStatus unknownNCT01200745Not applicable
• Efficacy and Safety Study of Topical Capsaicin in Painful Diabetic NeuropathyCompletedNCT00993070Phase 2/3
• Study of NGX-4010 With the Use of Open Label Lidocaine (2.5%)/Prilocaine (2.5%) Cream for the Treatment of Postherpetic Neuralgia (PHN)CompletedNCT00916942Phase 2
• Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck PainWithdrawnNCT00795106Phase 2
• Cervical Capsaicin for Labor Induction and Pain ReliefWithdrawnNCT00771511Phase 4
• Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic SkinTerminatedNCT00697034Phase 4
• Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00300222Phase 3
• Effect of NGX-4010 on ENFD and Sensory FunctionCompletedNCT00254449Phase 1
• Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN)CompletedNCT00233155Phase 2
• Response of Topical Capsaicin in Alopecia AreataCompletedNCT00176969Phase 4
• Efficacy and Safety of ALGRX 4975 in Treatment of Postoperative Pain After Hernia RepairCompletedNCT00146198Phase 2
• Efficacy and Safety of ALGRX 4975 in the Treatment of Postoperative Pain After Gall Bladder RemovalCompletedNCT00133133Phase 2
• ALGRX 4975 After Total Knee ReplacementCompletedNCT00132392Phase 2
• ALGRX 4975 in the Treatment of Patients With Morton's NeuromaCompletedNCT00130962Phase 2
• ALGRX 4975 in the Treatment of Tennis ElbowCompletedNCT00130949Phase 2
• Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00115310Phase 3
• An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic PainTerminatedNCT00089557Phase 2
• Capsaicin to Control Pain Following Third Molar ExtractionCompletedNCT00088686Phase 2
• Study of NGX-4010 for Treatment of Painful HIV-Associated NeuropathyTerminatedNCT00085761Phase 3
• Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic PainCompletedNCT00082316Phase 2
• Controlled Study of NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00068081Phase 3
• Study of NGX-4010 for the Treatment of Painful HIV-Associated NeuropathyCompletedNCT00064623Phase 3
• NGX-4010 for the Treatment of Postherpetic NeuralgiaCompletedNCT00061776Phase 2/3

← Capsaicin overview